e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

14.77 +0.09 (+0.61%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Can This Stock Grow Despite a COVID Testing Decline? ↗

October 05, 2021

Fulgent has capitalized on COVID-19 testing, but even though this segment of its business might slow, there are plenty of reasons to own the company.

Via The Motley Fool

These 3 Top Healthcare Stocks Are Screaming Buys Right Now ↗

September 29, 2021

If the market crashes these companies could be insulated.

Via The Motley Fool

Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program

September 23, 2021

From Fulgent Genetics, Inc.

Via Business Wire

3 Unstoppable Healthcare Stocks to Buy With Just $1,000 ↗

September 22, 2021

It doesn't take much when you buy great companies and let them grow.

Via The Motley Fool

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

While You're Waiting For That Elusive Silver Squeeze... ↗

June 30, 2021

You may be missing an actual squeeze elsewhere.

Via Talk Markets

The 1 Stock I'd Buy Right Now ↗

September 18, 2021

The pandemic isn't over yet.

Via The Motley Fool

Fulgent Genetics's Return on Invested Capital Overview ↗

September 14, 2021

Pulled from Benzinga Pro data, Fulgent Genetics (NASDAQ:FLGT) posted Q2 earnings of $98.90 million, an increase from Q1 of 62.95%. Sales dropped to $153.62 million, a 57.26%...

Via Benzinga

10 Million Reasons I'm Not Selling Fulgent Genetics ↗

September 02, 2021

The company is about to shock Wall Street.

Via The Motley Fool

Have $500? 3 Absurdly Cheap Healthcare Stocks Long-Term Investors Should Consider Buying Right Now ↗

August 24, 2021

Everyone loves a discount.

Via The Motley Fool

2 Types of Growth Stocks Investors Should Be Holding in Their Portfolios Today ↗

August 12, 2021

Hedging against COVID-19 could prove to be crucial in keeping your portfolio safe.

Via The Motley Fool

Topics Economy

85 Biggest Movers From Yesterday ↗

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

Why Shares of Fulgent Genetics Are Plunging Today ↗

August 10, 2021

Spectacular quarterly results were not enough to satisfy investors' appetites.

Via The Motley Fool

Topics Death

54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 10, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

28 Stocks Moving in Tuesday's Pre-Market Session ↗

August 10, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also...

Via Benzinga

Fulgent Genetics Stock Falls As Q2 Earnings Miss Street Estimates; Lowers FY21 Sales Outlook ↗

August 10, 2021

Fulgent Genetics Inc (NASDAQ: FLGT) reported after the close of the market on Monday that its second-quarter revenues increased nearly ninefold, driven primarily by...

Via Benzinga

Topics Earnings

Fulgent Genetics, Inc. Common Stock (FLGT) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

FLGT earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Fulgent Genetics Q2 Earnings ↗

August 09, 2021

Shares of Fulgent Genetics (NASDAQ:FLGT) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 1400.00% year...

Via Benzinga

Fulgent Genetics Reports Second Quarter Financial Results

August 09, 2021

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests

August 09, 2021

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Acquisition of CSI Laboratories

August 09, 2021

From Fulgent Genetics, Inc.

Via Business Wire

CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021

July 26, 2021

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021

July 26, 2021

From Fulgent Genetics, Inc.

Via Business Wire

Why Shares of Fulgent Genetics Rose 77% in the First Half of 2021 ↗

July 19, 2021

The stock has traded with the ebbs and flows of COVID cases, but its testing has consistently delivered for its impressive list of customers.

Via The Motley Fool

3 Things About Fulgent Genetics That Smart Investors Know ↗

July 14, 2021

Few companies had bigger tailwinds from COVID-19. What comes next could be even more exciting.

Via The Motley Fool

5 Stocks to Own for the Surge in Coronavirus Variants ↗

July 14, 2021

Despite easing restrictions, COVID is going to be around a lot longer than many think.

Via The Motley Fool

3 Stocks I'd Buy if the Market Crashes ↗

July 13, 2021

A steep sell-off is required for these stocks to become bargain buys.

Via The Motley Fool

Is It Too Late to Buy Fulgent Genetics Stock? ↗

June 29, 2021

All is not lost for this COVID-19 testing company.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy